GoodRx Holdings Inc GDRX

NAS: GDRX | ISIN: US38246G1085   30/04/2025
4,630 USD (-0,64%)
(-0,64%)   30/04/2025
Grafiek GoodRx Holdings Inc Grafiek GoodRx Holdings Inc
woensdag 7 mei 2025, 22:00
Kwartaalcijfers (1ste kwartaal)

GoodRx Holdings Inc in het nieuws

18 juli 2024 · Boehringer Ingelheim and GoodRx announce exclusive patient affordability initiative for Adalimumab-adbm injection, Boehringer's biosimilar to Humira® · Persbericht

21 juni 2024 · Lost Money on GoodRx Holdings, Inc.(GDRX)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky · Persbericht

18 juni 2024 · Class Action Filed Against GoodRx Holdings, Inc. (GDRX) Seeking Recovery for Investors - Contact Levi & Korsinsky · Persbericht

17 juni 2024 · Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Class Action Lawsuit Against GoodRx Holdings, Inc. (GDRX) · Persbericht

14 juni 2024 · Investors in GoodRx Holdings, Inc. Should Contact Levi & Korsinsky Before June 21, 2024 to Discuss Your Rights - GDRX · Persbericht

13 juni 2024 · SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GoodRx · Persbericht

11 juni 2024 · GDRX Investors Have Opportunity to Lead GoodRx Holdings, Inc. Securities Fraud Lawsuit · Persbericht

10 juni 2024 · Deadline in 11 Days: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Class Action Lawsuit Against GoodRx Holdings, Inc. (GDRX) · Persbericht

6 juni 2024 · SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GoodRx · Persbericht

6 juni 2024 · Levi & Korsinsky Reminds GoodRx Holdings, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 21, 2024 - GDRX · Persbericht

Profiel GoodRx Holdings Inc

Internet Software/Diensten
Technologische diensten

Website: goodrx.com

Hoofdzetel: Santa Monica, CA vlag Verenigde Staten

CEO: Doug Hirsch

Werknemers: 893

Mijn selecties